Epidemiology, clinical and complications profile of diabetes in Saudi Arabia: A review

Annals of Saudi Medicine

Volumn 27, Issue 4, 2007, Pages 241-250

  Elhadd, Tarik A ^a   Al Amoudi, Abdallah A ^a   Alzahrani, Ali S ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; HERBACEOUS AGENT; IMMUNOSUPPRESSIVE AGENT; INSULIN; METFORMIN;

CLINICAL FEATURE; CONSANGUINEOUS MARRIAGE; DEVELOPING COUNTRY; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIET RESTRICTION; GENDER BIAS; GENETIC PREDISPOSITION; HEALTH CARE DELIVERY; HEALTH EDUCATION; HEALTH SERVICE; HEMOGLOBINOPATHY; HERBAL MEDICINE; HUMAN; HYPERGLYCEMIA; INFECTIOUS COMPLICATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIFESTYLE; MATURITY ONSET DIABETES MELLITUS; MIDDLE EAST; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANDEMIC; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RELIGION; REVIEW; SAUDI ARABIA; URBAN RURAL DIFFERENCE;

EID: 34948843660     PISSN: 02564947     EISSN: 13199226     Source Type: Journal    
DOI: 10.5144/0256-4947.2007.241     Document Type: Review

References (101)

1. Amos A, McCarthy D, Zimmit P. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet Med 1997; 14(S1-S85).
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimates for the year 2000 and projection for 2030. Diabetes Care 2004; 27(5):1047-53
3. Ledward RS. Initial findings in a new obstetric unit in Saudi Arabia. Trop Doct 1982; 12(2):63.
4. Bacchus RA, Bell JR, Madkour M, Kilshaw. The prevalence of diabetes mellitus in male Saudi Arabs. Diabetologia 1982; 23(4):330.
5. Al-Nuaim AR. Prevalence of glucose intolerance in urban and rural communities of Saudi Arabia, Diabet Med 1997; 14(7):595-602.
6. Al-Nozha MM, Al-Matouq MA, Al-Mazrou YY, et al. Diabetes in Saudi Arabia. Saudi Med J 2004; 25(11): 1603-10
7. el-Hazmi MA, al-Swailem AR, Warsy SA, al-Swailem AM, Sulimani R. al-Mashari AA. Consanguinity among Saudi Arabian population. J Med Genetics 1995; 32(8):623.
8. Cook GC. Rapid glucose absorption in Arabs in Saudi Arabia compared in that in Africans in Zambia. Br Med J 1976; 201(6011):688-89.
9. Gupta OP, Joshi MR, Dave SK. Prevalence of diabetes mellitus in India. Adv Metabol Disord 1978; 9:147-65.
10. Fatani HH. Prevalence of diabetes mellitus in rural Saudi Arabia. Diabetes Care 1987; 10(2):180.
11. Anukote CC. Epidemiology studies of diabetes mellitus in Saudi Arabia-Part 1-screening of 3158 males in King Saud University. J Soc Health 1990; 110(6):210-63.
12. el-Hazmi MA, Warsy AS, al-Swailem AR, al-Swailem AM, Sulimani R., Al Meshari AA. Diabetes mellitus and impaired glucose tolerance in Saudi Arabia Annals Saudi Med 1996; 16(4):381-385.
13. el-Hazmi MA, Warsy AS. Prevalence of overweight and obesity in diabetic and non-diabetic Saudi Arabians. East Mediterr Health J. 2000; 6(2-3):276-82.
14. Al-Nuaim RA. Effects of overweight and obesity on glucose intolerance and dyslipidemia in Saudi Arabia: an epidemiological study. Diabet Res Clin Pract 1997; 36(3):181-91
15. Salman H, Abanamy A, Ghassan B, Khalil M. Childhood diabetes in Saudi Arabia. Diabet Med 1991; 8(2):176.
16. Kulyalat HA, Narchi H. A twelve year study of the incidence of childhood Type-1 diabetes mellitus in the Eastern Province of Saudi Arabia. J Ped Endocrinol Metabol 2000; 13(2):135-40
17. Fonseca V, Laajam MA, Tongia RK. Non-ketotic diabetes mellitus in young non obese Saudi Arabians. East Afr Med J 1985; 62(1):21-25
18. Famuyiwa OO, Sulimani RA, Laajam MA, Al-Jasser SJ, Mekki MO. Diabetes mellitus in Saudi Arabia: the clinical pattern and complications in 1000 patients. Ann Saudi Med 1992; 12:140-51.
19. Alhussein KA, Rama NR, Ahmed M, Rozemullar E. HLA-DPBI0401 is associated with dominant protection against Type-1 diabetes in general Saudi population in subjects with risk DR/DQ haplotype. Eur J Immunogenet 2003; 36(2)115.
20. Abdullah MA, Salman H, Bahakim H, Gad al Rab MO, Halim K, Abanmy A. Antithyroid and other organ-specific antibodies in Saudi Arab diabetic and normal children. Diabet Med 1990; 7(1):50-52.
21. Qari F, Damnan S. Schmidt's syndrome in a Saudi family. Saudi Med J 2000; 21(1):93-95.
22. el-Hazmi MA, al-Swailem AR, al-Fawaz I, Warsy AS, al-Swailem AM. Diabetes mellitus in children suffering from beta thalassemia. J Trop Pediatr 1994; 40(5):261.
23. Taha D, Barbar M, Kanaan, Williamson Belfe J. Neonatal diabetes mellitus, congenital hypothyroidism, hepatic fibrosis, polycystic kidneys and congenital glaucoma: a new autosomal recessive syndrome. Am J Med Genet 2003; 122A (3):269.
24. Woodhouse NJ, Sakatti N. A syndrome of hypogonadism, alopecia, diabetes mellitus, mental retardation, deafness and ECG abnormalities. J Med Genet 1983; 20(3): 216.
25. AlShawaf T, Akeil A, Mograby SA. Gestational diabetes and impaired glucose tolerance in Riyadh. Br J Obstet Gynaecol 1988; (1):84-90.
26. Mwambingen FT, Al Meshari AA, Akeii A. The problem of grand multiparity in current obstetric practice. Int J Obstet Gynaecol 1988; 26(3):355.
27. Khawja SS, AlSuleiman SA, al-Sibai MH, Screening for gestational diabetes in a teaching hospital in Saudi Arabia. Aust N Z Obstet Gynaecol 1989; 29(3pt1):209-11.
28. al-Teheawy MM. Prenatal care in primary health care centres of Al-Hassa, Saudi Arabia. J Egypt Public Health Assoc 1992; 67(1-2 PubMed):37-51.
29. Nasrat HA, Salih M, Ardawi M, Ghafouri H. Outcome of pregnancy in diabetic mothers. Into J Gynaecol Obstet 1993; 10(8):29.
30. Nasrat HA, Fageeh W, Abalkail B, Yamani T, Ardawi M. Determinant of pregnancy outcome in patients with gestational diabetes. Int J Gynaecol Obstet 1996; 53(2):117.
31. Subande AA, Al-Bar A, Archibong EL Diabetes and perinatel loss. A continuing problem. Saudi Med J 2000; 21(2):161-63.
32. El Mallah KO, Narch H, Kulyate NA, Shaban MS. Gestational and pregestational diabetes. Comparison of maternal characteristics and outcome. Int J Gynaecol Obstet 1997; 58(2):203.
33. Narchi H, Kulaylat NA, High incidence of Down's Syndrome in infants of diabetic mothers. Arch Dis Child 1997; 77(3):242.
34. O'Dea K. Westernization and non-insulin dependent diabetes in Australian aborigines. Ethn Dis 1991; 1(2):171-187.
35. Anokute CC. Suspected synergism between consanguinity and familial aggregation in type-2 diabetes in Saudi Arabia. J R Soc Health 1992; 112(4):167.
36. AlNuaim A. High prevalence of metabolic risk factors for cardiovascular diseases among Saudi population aged 30-64 years. Int J Cardiol 1997; 62(3):227.
37. AlRajeh A, Awada A. Stroke in Saudi Arabia. Cerebrovasc Dis 2002; 13(1):3.
38. Osman AK, Al-Nozha MM. Risk factors of coronary artery disease in different regions of Saudi Arabia East Mediterr Health J. 2000; 6(2-3):465-74.
39. AlKhadra AH. Clinical profile of young patients with acute myocardial infraction in Saudi Arabia. In J Cardiol 2003; 91(1):9.
40. Alhumaidi MA. Probability of coronary artery disease among patients attending primary health care centres in southwest Saudi Arabia. Ethn Dis 2000; 10(3):350.
41. Kuskowska X, Wolk A, Rossners Y. Prevalence of overweight in Sweden: a cross-sectional study of representative world population. J Int Med 1990; 227: 241-246 PubMed.
42. Al-Turki YA. The prevalence of overweight and obesity amongst hypertensive and diabetic adult patients in primary health care. Saudi Med J 2000; 21(4):340-43.
43. Al Harithy RN, Al Ghamdi S. Serum resistin, adiposity and insulin resistance in Saudi women with type-2 diabetes. Ann Saudi Med 2005; 25(4):283.
44. Aldahgri N, Chetty R, McTerran PG, Al-Rubean K, Al-Attas O, Jones A, Kumar S. Serum resistin is associated with C-reactive protein & LDL cholesterol in type-2 diabetes and coronary artery disease in Saudi population. Cardiovasc Diabetol 2005; 4(1):10-14.
45. Akbar DH. Is hypertension common in hospitalized type-2 diabetic patients? Saudi Med J 2001; 22(2):139-41.
46. Warsy AS, el-Hazmi MA. Diabetes mellitus, hypertension and obesity: common multifactorial disorders in Saudi East Meditter Health J 1999; 5(6):1236-42.
47. Al-Shammari SA, Ali M, Al-Shammari A, al-Maatoug M, Tennier A, Armstrong K. Blood lipid concentration and other cardiovascular risk factors among Saudi's. Fam Pract 1994; 11(2):153-58.
48. AlRajih S, Larbi EB, Bademosi O et al. Stroke register: experience from the Eastern Province of Saudi Arabia. Cerebrovasc Dis 1998; 8(2):86.
49. Awada A, Al Rajeh S. The Saudi stroke data bank. Analysis of the first 1000 cases. Acta Neurol Scand 1999; 100(4):265-69.
50. Qari FA. Profile of stroke in a teaching university hospital in the Western region. Saudi Med J 2000; 11:1030-33.
51. AlRajeh S, Awada A. Stroke in Saudi Arabia. Cerebrovasc Dis 2002; 13(1):3 PubMed-8
52. Al Zahrani HA. The distribution of peripheral arterial disease in a defined population of elderly high risk Saudi patients. Int Angiol 1997; 16(2):123.
53. AlNozha M, Aldaghri N, Bartlett WA et al. Serum homocysteine concentration is related to diabetes mellitus but not to coronary artery disease in Saudi Arabia. Diabetes Ob Metab 2002; 4(2):118-23.
54. Ajabnoor MA, Al-Ama MN, Banjar Z, Rafee AA, Sheweita SA. Homocysteine levels and other biochemical parameters of cardiovascular disease in patients with diabetes, Med Sci Monit 2003; 9(12):CR523.
55. Elhadd TA, Neary R, Abdu TA et al. Influence of hormonal changes during the normal menstrual cycle in young healthy women on soluble adhesion molecules, plasma homocysteine, free radical markers and lipoprotein fractions. Int Angiol 2004; 22(3):222.
56. Akhar DH. The Effect of metformin and sulphonylurea on c-reactive protein in well controlled patients with type-2 diabetes with metabolic syndrome, Endocrine 2003; 20(3):215.
57. Abu El Asrar AM, Al-Rubean KA, Al-Amro SA, Kangave D. Risk factors for diabetic retinopathy among Saudi diabetics. Int Ophthalmol 1998-1999; 22(3 PubMed):155-61.
58. The Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of IDDM. New Eng J Med 1993; 329:877-986.
59. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type-2 diabetes. Lancet 1998; 12; 352(9131 PubMed):837-53.
60. Abu El Asrar AM, Al-Rubean KA, Al-Amro SA, Moharam OA, Kangave D. Retinopathy as a predictor for other diabetic complications, Int Ophthalmol 2001; 24(1):1.
61. Alghadyan AA. Retinal vein occlusion in Saudi Arabia. Possible role of dehydration. Ann Ophthalmol 1993; 25(10):394-98.
62. Akbar DH, Mira SA, Zawawi TH, Malibary HM. Subclinical neuropathy a common complication in Saudi diabetics. Saudi Med J 2000; 21(5):433-37.
63. Fonseca V, Laajam MA, Tongia RK. Asymptomatic autonomic neuropathy in Saudi diabetics. Saudi Med J 1985; 6(1):38-42.
64. Tongia RK, Fonseca V, Laajam MA. Abnormal systolic time interval in asymptomatic Saudi diabetics. Saudi Med J 1984; 5:415-20.
65. Neilsen JV. Peripheral neuropathy, hypertension, foot ulcers and amputations among Saudi Arabian patients with Type-2 diabetes. Diabetes Res Clin Pract 1998; 41(1):63-69.
66. Abbott CA, Garrow AP, Morris J, Van Ross ER, Boulton AJ. North-West diabetes foot care study. Foot ulcer risk is lower in South Asian and Afro-Caribbean compared with Europeans patients in UK. Diabetes Care 2005; 28(8):1869 PubMed -75.
67. al Qidawi SA, Khan MA, Hussein SR, Malik MS. Diabetic neuroarthropathy Saudi Med J 2001; 22(2):42-47
68. Qari FA, Akbar DH. Diabetic foot presentation and treatment. Saudi Med J 2000; 21(5):443-46
69. El Sakka AL, Tayeb KA. Erectile dysfunction risk factors in non-insulin dependent diabetic Saudi patients. J Urol 2003; 169(3):1043.
70. Al Helali NS, Abolfotouh MA, Ghanem HM. Pattern of erectile dysfunction in Jeddah city. Saudi Med J 2001; 22(1):34-8.
71. Onuora VC, Koko AH, Patil MG. Management of impotence in a developing country. East African Med J 1995; 72(7):415-57
72. Al Khader AA. Impact of diabetes on renal disease in Saudi Arabia. Nephrol Dialysis Transplant 2001; 16: 2132-35.
73. Mitwalli A, Al-Swailem AR, Aziz KMS et al. Etiology of end stage renal disease in two regions of Saudi Arabia. Saudi J Kidney Dis Transplant 1997; 6(1):16-20.
74. AlZaid A, Sobki S, De Silva V. Prevalence of microalbuminuria in Saudi Arabian with non-insulin dependent diabetes: a clinic based study. Diabetes Res Clin Pract 1994; 26:115-120
75. Al-Homrany MA, Abdelmoneim I. Significance of proteinuria in type-2 diabetic patients treated at a primary health care centre in Abha City, Saudi Arabia. West Afr J Med 2004; 22(3):211-14.
76. Nelson D, Bennet P, Beck G. Development and progression of renal disease in Pima Indians with NIDDM. N Eng J Med 1996; 335-36.
77. SCOT (Saudi Committee of Organ Transplantation) Annual Report Kingdom of Saudi Arabia Ministry of Health; 1999.
78. Hussein M, Moeji J, Ronj'leh H, El-Sayed H. Observation in a Saudi Arabian dialysis population over 13 years period. Nephrol Dial Transp 1994; 9:1072-76 PubMed.
79. Jondeby M, Delos Santos G, Al Ghamdi A et al Caring for hemodialysis patients: present, past and future. Saudi Med J 2001; 22:199-204.
80. Saxena AK, Panhotra BR. The susceptibility of patients with type-2 diabetes to hepatitis-C virus during long-term haemodialysis. Swiss Med Wkly 2003; 133(46-46 PubMed):611-18.
81. Souqiyyeh M, Shaheen F, Sheikh I et al. Diabetes and renal transplantation: Saudi experience. Saudi J Kidney Dis Transplant 2000; 11:25-30 PubMed.
82. Anokute CC. Suspected synergism between consanguinity and familial aggregation of Type-2 diabetes in Saudi Arabia. J R Soc Health 1992; 112(4):167.
83. Alawamy BH. Thalassaemic syndromes in Saudi Arabia: meta-analysis of local studies. Saudi Med J 2000; 21(1):8-17.
84. Niazi GA. Glucose 6 phosphate dehydrogenase deficiency and diabetes mellitus. Int J Haemetol 1991; 54(4):295-98.
85. Sulimani RA, Famuyiwa FO, Laajam MA. Diabetes mellitus and Ramadan fasting: the need for critical appraisal. Diabet Med 1988; 5(6):589-91.
86. Uysal AR, Erdogan MF, Sahin G, Kamel N, Erdogan G. Clinical and metabolic effects of fasting in 41 type-2 diabetic patients during Ramadan. Diabetes Care 1998; 31(11):2033.
87. Al-Arouj M, Bouguera R, Buse J, Al-Rubean KA, Hassanien M, Ibrahim M et al. Recommendation for management of diabetes during Ramadan. Diabetes Care 2005; 28(9): 2305.
88. Elhadd TA, Al-Amoudi AA. Recommendation for management of diabetes during Ramadan. The need for scientific research and patient education. Diabetes Care 2006; 29(3): PubMed 744-45.
89. Lajaam MA. Ramadan fasting and non-insulin dependent diabetes: effect on metabolic control. East Afr Med J 1990; 67(10):732-36.
90. Elhadd TA, Bissar LS, AlGhamdi SMG, Bashir M, Al-Amoudi AA. Low education provided to diabetic patients for fasting Ramadan: a questionnaire survey. 87th Meeting of American Endocrine Society 2005, San Diego, CA, USA P3-519 (Abstract).
91. AlGhamdi SM, Akbar HO, Qari YA, Fathaldin OA, Al Rashed RS. Patter of admission to hospitals during Muslim pilgrimage (Hajj). Saudi Med J 2003; 24(10):1073-76.
92. Saxena AK, Panhotra BR. The susceptibility of patients with type-2 diabetes to hepatitis-C virus during long-term haemodialysis. Swiss Med Wkly 2003; 133(45-46 PubMed):611-16.
93. Akbar DH, Siddique AM, Ahmed MM. Prevalence of type-2 diabetes in patients with hepatitis C and B virus infection in Jeddah, Saudi Arabia. Med Princ Pract 2002; 11(2):82 PubMed -85.
94. Makeen AM. The association of infective hepatitis type A and diabetes mellitus. Trop Geogr Med 1992;44(4):362-64.
95. Oli JM, Nwokolo C. Diabetes after infectious hepatitis: a follow up study. Br Med J 1979; 1(6168):926-27.
96. Al Jahdali H, AlZahrani K, Amene P, Memish Z, AlShemmri A, Moamary M, Alduhaim A. Clinical aspects of military tuberculosis in Saudi adults. Int J Tuberc Lung Dis 2000; 4(3):252-55.
97. Bukhary ZA, AlRajeh AA. Extrapulmonary tuberculosis: clinical presentation and outcome. Saudi Med J 2004; 25(7):881-85.
98. Shohaib S, Scrimgreor E, Shaeyra P. Tuberculosis in active dialysis patients in Jeddah. Am J Neph 1999; 19:34-37.
99. Al Rowis N. Herbal medicine use in treatment of diabetes mellitus. Saudi Med J 2002; 23(1):1327-31.
100. Al Saeedi M, ElZubier AG, Bahnassi AA, Al-Dawood KM. Pattern and belief and the use of traditional remedies by diabetic patients in Mecca, Saudi Arabia. East Meditter Health J 2003; 9(1-2):99-107.
101. Bugusz MJ, Al Tufail M, Hassan H. How natural are natural Remedies? A Saudi. Adverse Drug Reaction Toxicology Rev 2002; 21(4):219.